Drug ID: | NPD3027 |
Drug Name: | CA4P |
Molecular Formula: | C18H22O6 |
Canonical SMILES: | COc1cc(cc(c1OC)OC)[C@H](Cc1ccc(c(c1)O)OC)O |
Standard InCHI: | InChI=1S/C18H22O6/c1-21-15-6-5-11(8-14(15)20)7-13(19)12-9-16(22-2)18(24-4)17(10-12)23-3/h5-6,8-10,13,19-20H,7H2,1-4H3/t13-/m0/s1 |
Standard InCHIKey: | LGZKGOGODCLQHG-ZDUSSCGKSA-N |
Max Developmental Stage: | Phase 3 |
Max Developmental Stage Source: | DrugBank |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | |
DrugBank | DB05284 |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 334.14 |
ALogP | -1.1158 |
MLogP | 2.78 |
XLogP | 1.707 |
HDA | 1 |
HBD | 2 |
Rotatable Bonds | 13 |
TPSA | 77.38 |
RO5 Violation | 0 |